Offer - Urjas Oil for just ₹ 1
Vepan CV 250/62.5 Tablet DT is a prescription medicine that is available as a Tablet. Vepan CV 250/62.5 Tablet DT also has some secondary and off-label uses. These are listed below.
The correct dosage of Vepan CV 250/62.5 Tablet DT depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Vepan CV 250/62.5 Tablet DT can also lead to other problems, which have been listed below. These side effects of Vepan CV 250/62.5 Tablet DT are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Vepan CV 250/62.5 Tablet DT's effect during pregnancy is Safe and Safe while nursing. Warnings related to Vepan CV 250/62.5 Tablet DT's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Jaundice must refrain from the use of Vepan CV 250/62.5 Tablet DT since this can cause severe adverse effects. Other conditions have been mentioned below in the Vepan CV 250/62.5 Tablet DT contraindications section.
Drug reaction of Vepan CV 250/62.5 Tablet DT with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Vepan CV 250/62.5 Tablet DT is considered not safe while driving, and is not addictive.
Vepan CV 250/62.5 Tablet DT is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Vepan CV 250/62.5 Tablet DT safe for pregnant women?
Vepan Cv is safe to take during pregnancy.
Is the use of Vepan CV 250/62.5 Tablet DT safe during breastfeeding?
Vepan Cv does not show any harmful effects in lactating women.
What is the effect of Vepan CV 250/62.5 Tablet DT on the Kidneys?
Vepan Cv rarely harms the kidneys.
What is the effect of Vepan CV 250/62.5 Tablet DT on the Liver?
Vepan Cv is not harmful for the liver.
What is the effect of Vepan CV 250/62.5 Tablet DT on the Heart?
Using Vepan Cv does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Vepan CV 250/62.5 Tablet DT unless your doctor advises you to do so -
Is this Vepan CV 250/62.5 Tablet DT habit forming or addictive?
Vepan CV 250/62.5 Tablet DT is not addictive in nature.
Interaction between Food and Vepan CV 250/62.5 Tablet DT
Some foods when eaten with Vepan CV 250/62.5 Tablet DT can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Vepan CV 250/62.5 Tablet DT
Information about the interaction of Vepan CV 250/62.5 Tablet DT and alcohol is not currently available because this topic has not been researched yet.
Yes Vepan Cv can be taken with diphenhydramine. Diphenhydramine does not appear to interfere with the efficacy of Vepan Cv. Hence, it is alright to take them together. However, if you feel any discomfort after taking this drug do not hesitate to inform your doctor.
Discontinuing Vepan Cv on your own can increase the chances of bacterial resistance and infection relapse. It is recommended that you always consult your doctor if you have decided to discontinue this medicine.
Yes, Vepan Cv can be taken with ibuprofen. No harmful drug interaction has been reported between them. It is safe to take Vepan Cv along with ibuprofen.
No, Vepan Cv does not cause constipation. It has not been reported by the patients who are taking it.
No, Vepan Cv does not make you drowsy. It has not been reported by the patients who are taking this drug.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
